It is estimated there are around 100,000 individuals living in the United States with sickle cell disease (SCD). Patients with sickle cell disease are predisposed to a variety of complications.
After many in emergency medicine celebrated a recent decision to end the X-waiver requirement and clear the way for easier medication-assisted treatment in the emergency department, the waiver of the
A 2015 study showed that when patients with opioid use disorder were started on buprenorphine with a behavioral intervention in the ED, they were 80% more likely to remain in treatment at 30 days.
Ongoing barriers to medication-assisted treatment for opioid use disorder contribute to a major care gap, with only 10% of patients seeking long-term OUD treatment able to receive it. It's time to imp
Before employing this nerve block when addressing shoulder dislocations, ensure familiarity with the nerve structure in the area and assess whether it will be appropriate in the patient.
Controversies Surrounding Ultrasound Guided Regional Anesthesia in the ED
Ultrasound guided regional anesthesia was first introduced in 1994, and it has since become a powerful tool for achieving ade
Pain Management in Vaso-occlusive Sickle Cell Crisis
Sickle cell disease (SCD) is the most common genetic blood disorder in the United States, affecting an estimated 100,000 persons.1 Vaso-occlusive
Introducing the ALTO Alternatives to Opioids Program
Steven Stack, MD, FACEP, an emergency medicine physician and immediate past-president of AMA, confronted the crisis in an open letter to America's
Nitrous Oxide for Pediatric Sedation
In the emergency department, we perform minor surgical procedures and invasive tests on children every day. Intravenous procedural sedation is often used to facil